By selecting the Yes option, leaving Amgen.com.sg option you understand that you are leaving the corporate page of Amgen Singapore and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen Singapore is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in Singapore. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
Throughout the history of medicine, the use of chemical compounds for the production of chemically synthesized drugs has predominated.
With the advancement of scientific technique, the use of biotechnology in health has opened the door to a new generation of medicines, biological ones. Unlike those of chemical origin, these types of drugs are proteins and are based on the study of human biology.
While the first biotechnological drugs, such as insulin, were modified versions of human proteins, complex molecular structures can now be designed by studying the molecular machinery of cells and using sophisticated technologies.
Taking advantage of the full potential offered by protein engineering, at Amgen we investigate human biology to advance the development of increasingly personalized medicine. Currently, we have a solid portfolio of 13 different therapeutic modalities to provide a broader response to many serious diseases or with treatment needs not yet covered.
Of the 13 modalities, 5 are based on immunotherapy and are intended for the treatment of a wide variety of tumors.